Report copyright - Inhibition of Apolipoprotein C-III with GalNAc …...Placebo/week (n=4) 15 mg/week (n=6) 30 mg/week (n=7) Placebo/month (n=4) 60 mg/month (n=6) Gender (M:F) 2:2 4:2 7:0 2:2 3:3 Age
Please pass captcha verification before submit form